These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Peptide-induced immune protection of CD8+ T cell-deficient mice against Friend retrovirus-induced disease. Kawabata H, Niwa A, Tsuji-Kawahara S, Uenishi H, Iwanami N, Matsukuma H, Abe H, Tabata N, Matsumura H, Miyazawa M. Int Immunol; 2006 Jan; 18(1):183-98. PubMed ID: 16352628 [Abstract] [Full Text] [Related]
25. Effects of vaccination against different T cell receptors on maintenance of immune function during murine retrovirus infection. Liang B, Marchalonis JJ, Zhang Z, Watson RR. Cell Immunol; 1996 Aug 25; 172(1):126-34. PubMed ID: 8806815 [Abstract] [Full Text] [Related]
26. Differences in the immune response during the acute phase of E-55+ murine leukemia virus infection in progressor BALB and long term nonprogressor C57BL mice. Panoutsakopoulou V, Little CS, Sieck TG, Blankenhorn EP, Blank KJ. J Immunol; 1998 Jul 01; 161(1):17-26. PubMed ID: 9647202 [Abstract] [Full Text] [Related]
27. Immunotherapy of murine leukemia. VIII. Efficacy of passive serum therapy of Friend leukemia virus-induced disease in immunocompromised mice. Genovesi EV, Livnat D, Collins JJ. J Natl Cancer Inst; 1983 Feb 01; 70(2):311-22. PubMed ID: 6337292 [Abstract] [Full Text] [Related]
28. Analysis of cytokine production in the colon of nude mice with experimental colitis induced by adoptive transfer of immunocompetent cells from mice infected with a murine retrovirus. Suriki H, Suzuki K, Baba Y, Hasegawa K, Narisawa R, Okada Y, Mizuochi T, Kawachi H, Shimizu F, Asakura H. Clin Immunol; 2000 Oct 01; 97(1):33-42. PubMed ID: 10998315 [Abstract] [Full Text] [Related]
29. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance. Schirrmacher V, Beutner U, Bucur M, Umansky V, Rocha M, von Hoegen P. J Immunol; 1998 Jul 15; 161(2):563-70. PubMed ID: 9670928 [Abstract] [Full Text] [Related]
30. Protection against autoimmune diabetes in mixed bone marrow chimeras: mechanisms involved. Mathieu C, Casteels K, Bouillon R, Waer M. J Immunol; 1997 Feb 01; 158(3):1453-7. PubMed ID: 9013991 [Abstract] [Full Text] [Related]
31. Delayed progression of a murine retrovirus-induced acquired immunodeficiency syndrome in X-linked immunodeficient mice. Hitoshi Y, Okada Y, Sonoda E, Tominaga A, Makino M, Suzuki K, Kinoshita J, Komuro K, Mizuochi T, Takatsu K. J Exp Med; 1993 Mar 01; 177(3):621-6. PubMed ID: 8382252 [Abstract] [Full Text] [Related]
32. Dissociation between lymphoproliferative responses and virus replication in mice with different sensitivities to retrovirus-induced immunodeficiency. Pozsgay JM, Reid S, Pitha PM. J Virol; 1993 Feb 01; 67(2):980-8. PubMed ID: 8380473 [Abstract] [Full Text] [Related]
33. Supplementation with Lactobacillus reuteri or L. acidophilus reduced intestinal shedding of cryptosporidium parvum oocysts in immunodeficient C57BL/6 mice. Alak JI, Wolf BW, Mdurvwa EG, Pimentel-Smith GE, Kolavala S, Abdelrahman H, Suppiramaniam V. Cell Mol Biol (Noisy-le-grand); 1999 Sep 01; 45(6):855-63. PubMed ID: 10541481 [Abstract] [Full Text] [Related]
34. Inhibition of murine AIDS (MAIDS) development in C57BL/6J mice by tyrphostin AG-1387. Sklan EH, Gazit A, Priel E. Virology; 2000 Dec 05; 278(1):95-102. PubMed ID: 11112485 [Abstract] [Full Text] [Related]
39. Correlation of anterior chamber-associated immune deviation with suppression of corneal epithelial rejection in mice. Yao YF, Inoue Y, Miyazaki D, Hara Y, Shimomura Y, Tano Y, Ohashi Y. Invest Ophthalmol Vis Sci; 1997 Feb 05; 38(2):292-300. PubMed ID: 9040461 [Abstract] [Full Text] [Related]
40. LP-BM5 murine retrovirus-induced immunodeficiency disease in allogeneic SCID chimeric mice. Inability to recognize a putative viral superantigen does not prevent induction of disease. Gilmore GL, Cowing C, Mosier DE. J Immunol; 1993 Jan 01; 150(1):185-9. PubMed ID: 8380187 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]